Business
Major new customer for COVID-19 diagnostic tests
Major new customer for COVID-19 diagnostic tests.
About this update from Batm Advanced Communications Ltd.
[{"type":"text","content":"\n \n \n \n RNS Number : 0233B\n BATM Advanced Communications Ld\n 05 October 2020\n \n \n \n \n LEI: \n 213800FLQUB9J289RU66\n \n \n 5 October 2020\n \n \n \n \n \n BATM Advanced Communications Limited\n \n \n (\"BATM\" or \"the Group\")\n \n \n \n \n \n BATM receives initial €4.3m order from major lab for COVID-19 diagnostic tests \n \n \n New significant customer order for Real-Time PCR test kits and instruments to be delivered this year \n \n \n \n \n \n BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is delighted to announce that it has received an initial \n €4.3m order for its COVID-19 Real-Time PCR diagnostic test kits and instruments. The order is from a major new customer and is to be delivered during Q4. The Group also provides an update on its new diagnostic tests being developed for respiratory diseases. \n \n \n \n \n \n The new customer is a significant global private laboratory group headquartered in Italy that provides COVID-19 testing throughout Europe, primarily for large businesses such as airports. The order is for the Group's Real-Time PCR (antigen) test that \n diagnoses whether an individual is currently infected with SARS-CoV-2, the virus that causes the disease Coronavirus 2019 (COVID-19). The customer has also purchased, as part of the same order, the Group's Ampilab qPCR and Extralab extractor instruments. BATM expects to receive further significant orders from this customer during Q4 and over the next 12 months.\n \n \n \n \n \n The Group's Ampilab 6 band qPCR instrument can run all standard test kits, but also advanced 5 (4+1) gene kits, such as the Group's newest COVID-19 antigen kit, with great speed and accuracy. As a result, it is a very cost efficient solution for labs. \n \n \n \n \n \n In addition, the Group is pleased to provide the following progress updates on its new testing kits:\n \n \n · \n The Group has started to deliver its COVID-19 antigen kit that was upgraded to detect the spike (S) protein, as announced on 15 July 2020. \n By being able to detect the S gene, this test can provide more accurate results by identifying the virus even in those with a low viral load, which is important in preventing non- and pre-symptomatic individuals from unknowing...